Formulation Strategies for Follow-on Biologics

Biosimilars Congress 2019 is included Keynote and Speakers sessions on the most recent examination intended to offer extensive worldwide exchanges that address current issues in Biosimilars Congress 2019

Taking the technological advances into account, the requirements for follow-on biologics have been discussed in the research project funded by the Health and Labour Sciences Research Grants: “Research on Evaluation of Quality, Efficacy, and Safety of Follow-on Biologics”. For this rapidly growing industry sector, little consensus or authoritative information is available yet regarding how and where biosimilar products will be produced. The future of their manufacturing is still up in the air. Much discussion among experts has focused on a dramatic up-tick in Contract Manufacturing Organizations (CMOs) involvement with process development projects and clinical-scale manufacturing for biosimilars.


·         Multiproduct or dedicated single product plants

·         Major markets or developing countries

·         Single-use, stainless steel or hybrid

·         Continuous bioprocessing


Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.